Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors
- PMID: 28703626
- DOI: 10.1177/2047487317720287
Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors
Abstract
Aims Identification and management of the Standard Modifiable Cardiovascular Risk Factors (SMuRFs; hypercholesterolaemia, hypertension, diabetes and smoking) has substantially improved cardiovascular disease outcomes. However, cardiovascular disease remains the leading cause of death worldwide. Suspecting an evolving pattern of risk factor profiles in the ST elevation myocardial infarction (STEMI) population with the improvements in primary care, we hypothesized that the proportion of 'SMuRFless' STEMI patients may have increased. Methods/results We performed a single centre retrospective study of consecutive STEMI patients presenting from January 2006 to December 2014. Over the study period 132/695 (25%) STEMI patients had 0 SMuRFs, a proportion that did not significantly change with age, gender or family history. The proportion of STEMI patients who were SMuRFless in 2006 was 11%, which increased to 27% by 2014 (odds ratio 1.12 per year, 95% confidence interval: 1.04-1.22). The proportion of patients with hypercholesterolaemia decreased (odds ratio 0.92, 95% confidence interval 0.86-0.98), as did the proportion of current smokers (odds ratio 0.93, 95% confidence interval 0.86-0.99), with no significant change in the proportion of patients with diabetes and hypertension. SMuRF status was not associated with extent of coronary disease; in-hospital outcomes, or discharge prescribing patterns. Conclusion The proportion of STEMI patients with STEMI poorly explained by SMuRFs is high, and is significantly increasing. This highlights the need for bold approaches to discover new mechanisms and markers for early identification of these patients, as well as to understand the outcomes and develop new targeted therapies.
Keywords: Myocardial infarction; atherosclerosis; coronary artery disease; risk factors.
Comment in
-
Cardiovascular disease: Time to identify emerging environmental risk factors.Eur J Prev Cardiol. 2017 Nov;24(17):1819-1823. doi: 10.1177/2047487317734898. Epub 2017 Oct 3. Eur J Prev Cardiol. 2017. PMID: 28969497 No abstract available.
Similar articles
-
Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.Lancet. 2021 Mar 20;397(10279):1085-1094. doi: 10.1016/S0140-6736(21)00272-5. Epub 2021 Mar 9. Lancet. 2021. PMID: 33711294
-
ST-Segment-Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors-How Common Are They, and What Are Their Outcomes?J Am Heart Assoc. 2019 Nov 5;8(21):e013296. doi: 10.1161/JAHA.119.013296. Epub 2019 Nov 1. J Am Heart Assoc. 2019. PMID: 31672080 Free PMC article.
-
Clinical outcomes of ST elevation myocardial infarction patients without standard modifiable risk factors.J Cardiol. 2024 Jul;84(1):41-46. doi: 10.1016/j.jjcc.2023.11.007. Epub 2023 Dec 2. J Cardiol. 2024. PMID: 38043707
-
Trends and Outcomes of ST-Segment-Elevation MI in Hospitalized Patients Without Standard Modifiable Cardiovascular Risk Factors.Curr Probl Cardiol. 2022 Sep;47(9):101271. doi: 10.1016/j.cpcardiol.2022.101271. Epub 2022 May 26. Curr Probl Cardiol. 2022. PMID: 35644501 Review.
-
Prevalence and Outcomes in STEMI Patients Without Standard Modifiable Cardiovascular Risk Factors: A National Inpatient Sample Analysis.Curr Probl Cardiol. 2022 Nov;47(11):101343. doi: 10.1016/j.cpcardiol.2022.101343. Epub 2022 Aug 5. Curr Probl Cardiol. 2022. PMID: 35934021 Review.
Cited by
-
Characteristics, Treatment, and Mortality of Patients Hospitalized for First ST-Segment Elevation Myocardial Infarction without Standard Modifiable Risk Factors in China.Rev Cardiovasc Med. 2023 Sep 5;24(9):249. doi: 10.31083/j.rcm2409249. eCollection 2023 Sep. Rev Cardiovasc Med. 2023. PMID: 39076397 Free PMC article.
-
Differential circulating cytokine profiles in acute coronary syndrome versus stable coronary artery disease.Sci Rep. 2024 Jul 27;14(1):17269. doi: 10.1038/s41598-024-68333-7. Sci Rep. 2024. PMID: 39068298 Free PMC article.
-
Evaluating Long-Term Outcomes in STEMI Patients with New Left Bundle Branch Block: The Impact of Modifiable Risk Factors.J Pers Med. 2024 Jul 19;14(7):771. doi: 10.3390/jpm14070771. J Pers Med. 2024. PMID: 39064025 Free PMC article.
-
Prognostic significance of triglyceride-glucose index in acute coronary syndrome patients without standard modifiable cardiovascular risk factors.Cardiovasc Diabetol. 2024 Jul 23;23(1):270. doi: 10.1186/s12933-024-02345-5. Cardiovasc Diabetol. 2024. PMID: 39044255 Free PMC article.
-
Association of Lipoprotein (a) and Standard Modifiable Cardiovascular Risk Factors With Incident Myocardial Infarction: The Mass General Brigham Lp(a) Registry.J Am Heart Assoc. 2024 May 21;13(10):e034493. doi: 10.1161/JAHA.123.034493. Epub 2024 May 18. J Am Heart Assoc. 2024. PMID: 38761082 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical